Efficient activation of viral genomes by levels of herpes simplex virus ICP0 insufficient to affect cellular gene expression or cell survival

Journal of Virology

Volumn 75, Issue 7, 2001, Pages 3391-3403

  Hobbs, W E ^a   Brough, D E ^a   Kovesdi, I ^a   DeLuca, N A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ARTICLE; CELL SURVIVAL; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE TARGETING; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; MESSENGER RNA SYNTHESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN DNA INTERACTION; TRANSACTIVATION; VIROGENESIS; VIRUS GENOME; VIRUS REACTIVATION;

ADENOVIRIDAE; ANIMALS; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; GENE EXPRESSION REGULATION, VIRAL; GENOME, VIRAL; HERPESVIRUS 1, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; PROMOTER REGIONS (GENETICS); TRANSGENES; UBIQUITIN-PROTEIN LIGASES;

EID: 0035106881     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.7.3391-3403.2001     Document Type: Article

References (60)

1. The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells
2. Vitronectin receptor antibodies inhibit infection of HeLa and A549 cells by adenovirus type 12 but not by adenovirus type 2
3. The herpes simplex virus type 1 regulatory protein ICP0 enhances virus replication during acute infection and reactivation from latency
4. Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies
5. Induction of the PML protein by interferons in normal and APL cells
6. Herpes simplex viruses with mutations in the gene encoding ICP0 are defective in gene expression
7. A herpes simplex virus type 1 mutant containing a deletion within immediate early gene 1 is latency-competent in mice
8. Activities of herpes simplex virus type I (HSV-1) ICP4 genes specifying nonsense peptides
9. Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4
10. Point mutations in the herpes simplex virus type 1 Vmw110 RING finger helix affect activation of gene expression, viral growth, and interaction with PML-containing nuclear structures
11. Construction and characterization of herpes simplex virus type 1 mutants with defined lesions in immediate early gene 1
12. Trans activation of transcription by herpes virus products: Requirement for two HSV-1 immediate-early polypeptides for maximum activity
13. ICP0 induces the accumulation of colocalizing conjugated ubiquitin
14. Specific destruction of kinetochore protein CENP-C and disruption of cell division by herpes simplex virus immediate-early protein Vmw110
15. The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms
16. HSV-1 IE protein Vmw110 causes redistribution of PML
17. A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein
18. A toxin-like material separable from type 5 adenovirus particles
19. Identification of immediate early genes from herpes simplex virus that transactivate the virus thymidine kinase gene
20. Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: Isolation and characterization of an ICP6 lacZ insertion mutant
21. Host species and strain differences affect the ability of an HSV-1 ICP0 deletion mutant to establish latency and spontaneously reactivate in vivo
22. Herpes simplex virus type 1 immediate-early protein Vmw110 reactivates latent herpes simplex virus type 2 in an in vitro latency system
23. Perturbation of cell cycle progression and cellular gene expression as a function of herpes simplex virus ICP0
24. Regulation of herpesvirus macromolecular synthesis. 1. Cascade regulation of the synthesis of three groups of viral proteins
25. Regulation of herpesvirus macromolecular synthesis: Sequential transition of polypeptide synthesis requires functional viral polypeptides
26. The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition
27. Activation of gene expression by herpes simplex virus type 1 ICP0 occurs at the level of mRNA synthesis
28. Transactivation of herpes simplex virus type 1 immediate-early gene expression by virion-associated factors is blocked by an inhibitor of cyclin-dependent protein kinases
29. Interaction of herpes simplex virus 1 a regulatory protein ICP0 with elongation factor 1δ ICP0 affects translational machinery
30. Herpes simplex virus 1 a regulatory protein ICP0 interacts with and stabilizes the cell cycle regulator cyclin D3
31. The PML growth-suppressor has an altered expression in human oncogenesis
32. The acute promyelocytic leukaemia-associated PML gene is induced by interferon
33. Attenuation of DNA-dependent protein kinase activity and its catalytic subunit by the herpes simplex virus type 1 transactivator ICP0
34. Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency
35. 1 into S phase of the cell cycle
36. The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain protein family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICP0
37. Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0)
38. PML, a growth suppressor disrupted in acute promyelocytic leukemia
39. Evidence for a direct role for both the 175,000- and 110,000-molecular-weight immediate-early proteins, of herpes simplex virus in the transactivation of delayed-early promoters
40. Herpes simplex virus type 1 immediate-early protein Vmw110 induces the proteasome-dependent degradation of the catalytic subunit of DNA-dependent protein kinase
41. A protein factor responsible for the early cytopathic effect of adenovirus
42. Regulation of herpesvirus macromolecular synthesis. V. Properties of alpha polypeptides made in HSV-1 and HSV-2 infected cells
43. Repression of gene expression upon infection of cells with herpes simplex virus type 1 mutants impaired for immediate-early protein synthesis
44. Stimulation of expression of a herpes simplex virus DNA-binding protein by two viral functions
45. Herpes simplex viruses and their replication
46. Herpes simplex virus genes involved in latency in vitro
47. Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture
48. Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins
49. Functional interactions between herpes simplex virus immediate-early proteins during infection: Gene expression as a consequence of ICP27 and different domains of ICP4
50. The herpes simplex virus immediate-early protein ICP0 affects transcription from the viral genome and infected-cell survival in the absence of ICP4 and ICP27
51. Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription
52. Transcription of herpes simplex virus immediate-early and early genes is inhibited by roscovitine, an inhibitor specific for cellular cyclin-dependent kinases
53. Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element
54. Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw110
55. The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies
56. Separation and characterization of herpes simplex virus type 1 immediate-early mRNAs
57. 5 promote adenovirus internalization but not virus attachment
58. Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22
59. Reactivation of latent herpes simplex virus by adenovirus recombinants encoding mutant IE-0 gene products
60. Adenovirus vector expressing functional herpes simplex virus ICP0